Craneware plc (LON:CRW - Get Free Report)'s share price passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 1,976.04 ($26.59) and traded as high as GBX 2,080 ($27.99). Craneware shares last traded at GBX 2,070 ($27.85), with a volume of 52,384 shares.
Wall Street Analysts Forecast Growth
Several brokerages recently weighed in on CRW. Shore Capital reaffirmed a "buy" rating on shares of Craneware in a report on Thursday, May 8th. Berenberg Bank reaffirmed a "buy" rating and issued a GBX 2,800 ($37.67) target price on shares of Craneware in a report on Tuesday, March 11th.
Get Our Latest Research Report on CRW
Craneware Price Performance
The firm's fifty day simple moving average is GBX 1,793.18 and its 200 day simple moving average is GBX 1,974.32. The firm has a market cap of £867.92 million, a P/E ratio of 74.63 and a beta of 0.28. The company has a debt-to-equity ratio of 12.22, a quick ratio of 1.00 and a current ratio of 0.63.
Craneware Cuts Dividend
The business also recently disclosed a dividend, which was paid on Thursday, April 17th. Shareholders of record on Thursday, March 20th were issued a dividend of GBX 13.50 ($0.18) per share. This represents a dividend yield of 0.71%. The ex-dividend date of this dividend was Thursday, March 20th. Craneware's dividend payout ratio (DPR) is presently 107.14%.
Insider Buying and Selling at Craneware
In related news, insider Will Whitehorn acquired 1,911 shares of the company's stock in a transaction on Thursday, April 24th. The stock was acquired at an average price of GBX 1,584 ($21.31) per share, with a total value of £30,270.24 ($40,729.60). Insiders own 19.28% of the company's stock.
About Craneware
(
Get Free Report)
The Craneware Group, the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group's Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care.
See Also
Before you consider Craneware, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Craneware wasn't on the list.
While Craneware currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
